ARCA BIOPHARMA INC - COM (ABIO)

Historical Portfolio Holders from Q2 2019 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
12.9M
Holdings value Q2 2024
$49.4M
Value change Q2 2024
+$26.3M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
30
Number of buys Q2 2024
18
Number of sells Q2 2024
-8
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 12.9M $49.4M +$26.3M $3.83 31
2024 Q1 7.2M $12.7M -$474K $1.76 21
2023 Q4 7.48M $12.7M +$358K $1.70 24
2023 Q3 3.26M $6.55M +$923K $2.01 22
2023 Q2 2.83M $5.75M +$631K $2.03 23
2023 Q1 2.52M $5.02M -$188K $1.99 26
2022 Q4 2.61M $6.19M -$935K $2.36 22
2022 Q3 2.22M $4.58M +$1.09M $2.06 21
2022 Q2 1.68M $4.17M +$1.36M $2.49 21
2022 Q1 1.13M $2.6M +$47.5K $2.30 20
2021 Q4 1.12M $2.41M -$1.26M $2.15 16
2021 Q3 1.53M $4.53M +$977K $2.96 15
2021 Q2 1.19M $4.16M +$1.09M $3.49 12
2021 Q1 876K $3.2M +$109K $3.65 14
2020 Q4 821K $3.29M +$1.62M $4.00 15
2020 Q3 412K $1.82M +$1.17M $4.41 8
2020 Q2 136K $898K -$420K $6.62 3
2020 Q1 201K $561K -$64K $2.81 5
2019 Q4 211K $1.2M +$238K $5.69 6
2019 Q3 170K $909K -$771K $5.35 6
2019 Q2 272K $1.96M +$1.96M $7.32 7